Acuta Capital Partners as of March 31, 2023
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 35 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals (APLS) | 14.1 | $19M | 291k | 65.96 | |
| Aadi Bioscience (AADI) | 9.9 | $13M | 1.8M | 7.24 | |
| Terns Pharmaceuticals (TERN) | 9.6 | $13M | 1.1M | 11.84 | |
| Cymabay Therapeutics | 5.6 | $7.7M | 879k | 8.72 | |
| Ventyx Biosciences (VTYX) | 5.1 | $7.0M | 209k | 33.50 | |
| Syndax Pharmaceuticals (SNDX) | 5.1 | $7.0M | 330k | 21.12 | |
| Kura Oncology (KURA) | 5.1 | $6.9M | 565k | 12.23 | |
| Iveric Bio | 5.0 | $6.8M | 281k | 24.33 | |
| United Therapeutics Corporation (UTHR) | 3.9 | $5.3M | 24k | 223.96 | |
| Rocket Pharmaceuticals (RCKT) | 3.8 | $5.1M | 298k | 17.13 | |
| Bellus Health Com New | 3.4 | $4.6M | 633k | 7.20 | |
| Sarepta Therapeutics (SRPT) | 3.3 | $4.5M | 33k | 137.83 | |
| Vaxcyte (PCVX) | 3.3 | $4.5M | 121k | 37.48 | |
| Celldex Therapeutics Com New (CLDX) | 3.2 | $4.4M | 122k | 35.98 | |
| Miragen Therapeutics (VRDN) | 3.1 | $4.3M | 168k | 25.44 | |
| Iveric Bio Call Option | 2.7 | $3.6M | 1.5k | 2433.00 | |
| Celldex Therapeutics Com New Put Option | 2.7 | $3.6M | 1.0k | 3598.00 | |
| Argen Se Sponsored Adr (ARGX) | 2.6 | $3.6M | 9.6k | 372.58 | |
| Gh Research Ordinary Shares (GHRS) | 1.4 | $1.9M | 243k | 7.99 | |
| 4d Molecular Therapeutics In (FDMT) | 1.3 | $1.8M | 105k | 17.19 | |
| Aclaris Therapeutics (ACRS) | 0.7 | $986k | 122k | 8.09 | |
| Iovance Biotherapeutics (IOVA) | 0.7 | $939k | 154k | 6.11 | |
| Alkermes SHS (ALKS) | 0.7 | $893k | 32k | 28.19 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.7 | $892k | 303k | 2.94 | |
| Pmv Pharmaceuticals (PMVP) | 0.5 | $737k | 155k | 4.77 | |
| Rezolute Com New (RZLT) | 0.5 | $703k | 366k | 1.92 | |
| Enliven Therapeutics (ELVN) | 0.5 | $678k | 31k | 21.90 | |
| Horizon Therapeutics SHS | 0.5 | $655k | 6.0k | 109.14 | |
| Savara (SVRA) | 0.3 | $388k | 199k | 1.95 | |
| Mersana Therapeutics (MRSN) | 0.2 | $247k | 60k | 4.11 | |
| Viking Therapeutics (VKTX) | 0.2 | $233k | 14k | 16.65 | |
| Keros Therapeutics (KROS) | 0.1 | $153k | 3.6k | 42.70 | |
| Hillevax (HLVX) | 0.1 | $110k | 6.7k | 16.53 | |
| Kinnate Biopharma | 0.0 | $31k | 5.0k | 6.25 | |
| Nuvation Bio *w Exp 07/07/2027 (NUVB.WS) | 0.0 | $11k | 91k | 0.12 |
